BGB-102
CAS: 807640-87-5
Ref. TM-T10531
1mg | 348.00 € | ||
5mg | 833.00 € | ||
10mg | 1,137.00 € | ||
25mg | 1,688.00 € | ||
50mg | 2,226.00 € |
Product Information
- JNJ-26483327
BGB-102 (JNJ-26483327) is a kinase inhibitor targeting FLT3 and YES1 and an antagonist targeting EGFR and VEGFR3, which may be useful in the study of macular degeneration and diseases associated with genetic disorders and malformations.
Chemical properties
Technical inquiry about: TM-T10531 BGB-102
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.